The rapid escalation of the Bundibugyo strain outbreak in the Democratic Republic of the Congo since its May 2026 declaration has defined trader sentiment, with cases surging past 5,200 and deaths exceeding 2,400 by mid-August amid conflict-driven mobility and the absence of an approved vaccine. This has locked in DRC while highlighting containment successes elsewhere, such as Uganda declaring its linked outbreak over in late July after rigorous tracing and no local transmission since June. Imported cases reached France and prompted treatment in Germany, but sustained spread has stayed limited, keeping regional neighbors on alert without confirmed new chains. Traders watch for border developments, response funding gaps, and any late-year spillover into additional African nations as the dominant swing factors through year-end.